MiR-130b inhibits proliferation and induces apoptosis of gastric cancer cells via CYLD. (Q38808381)

6 September 2017

title

MiR-130b inhibits proliferation and induces apoptosis of gastric cancer cells via CYLD. (English)

1 reference

6 September 2017

Baoyou Sun

1

1 reference

6 September 2017

Lei Li

2

1 reference

6 September 2017

Wendong Ma

3

1 reference

6 September 2017

Shikang Wang

4

1 reference

6 September 2017

Chunjin Huang

5

1 reference

6 September 2017

publication date

28 December 2015

1 reference

6 September 2017

1 reference

6 September 2017

volume

37

1 reference

6 September 2017

issue

6

1 reference

6 September 2017

page(s)

7981-7987

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-4632-3

6 September 2017

exact match

0 references

cites work

FBXL5 inhibits metastasis of gastric cancer through suppressing Snail1.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Molecular basis underlying inhibition of metastasis of gastric cancer by anti-VEGFa treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Inhibition of epidermal growth factor receptor signaling prohibits metastasis of gastric cancer via downregulation of MMP7 and MMP13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Clinical significance of CYLD downregulation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Over-expressing CYLD augments antitumor activity of TRAIL by inhibiting the NF-κB survival signaling in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Busulfan inhibits growth of human osteosarcoma through miR-200 family microRNAs in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Bufalin Inhibits the Differentiation and Proliferation of Cancer Stem Cells Derived from Primary Osteosarcoma Cells through Mir-148a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Modulation of FoxO1 expression by miR-21 to promote growth of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Regulation of growth of human bladder cancer by miR-192.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

MiR99a modulates MMP7 and MMP13 to regulate invasiveness of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

MiRNA-494 inhibits metastasis of cervical cancer through Pttg1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Downregulation of miR-130a contributes to cisplatin resistance in ovarian cancer cells by targeting X-linked inhibitor of apoptosis (XIAP) directly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

Retinoic acid-induced HOXA5 expression is co-regulated by HuR and miR-130a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4632-3

MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression

21 January 2018

1 reference

12 December 2020

A novel player in inflammation and cancer: the deubiquitinase CYLD controls HCC development

1 reference

12 December 2020

miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3.

1 reference

12 December 2020

miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222

1 reference

12 December 2020

MiR-130a overcomes gefitinib resistance by targeting met in non-small cell lung cancer cell lines

1 reference

12 December 2020

Down-regulation of miR-181b promotes apoptosis by targeting CYLD in thyroid papillary cancer

1 reference

12 December 2020

MiR-130a and MiR-374a Function as Novel Regulators of Cisplatin Resistance in Human Ovarian Cancer A2780 Cells

1 reference

12 December 2020

10.1007/S13277-015-4632-3

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1045977838

0 references

1 reference